Today

Agents

Chat

Arena

Discover

More

App

Protara Therapeutics Q2 EPS USD -0.36 - TARA News | Rallies

Protara Therapeutics Q2 EPS USD -0.36

TARA•2026-08-11

Protara Therapeutics reports second-quarter results

Aug. 11 (Reuters) - Protara Therapeutics Q2 net income USD -21.668 million.

Q2 income from operations USD -23.324 million
Q2 operating expenses USD 23.324 million

Related News

Odyssey Marine merger partner American Ocean Minerals names Paul Warmé CFO

OMEX•2026-08-11

Energy Focus Q2 FY26 net loss widens to $0.9 million; net sales more than doubled to $3.7 million year over year

EFOI•2026-08-11

Change Agents targets autonomous air defense expansion through IDGA engagement and Counter-UAS deal scouting

CHGA•2026-08-11

Phillips 66, Kinder Morgan, HF Sinclair approve $5 billion Western Gateway project

PSX•2026-08-11

Coya Therapeutics posts investor presentation on Treg-directed combination therapy for neurodegenerative diseases

COYA•2026-08-11